Altimmune, Inc. (ALT)
4.20
-0.04
(-0.94%)
USD |
NASDAQ |
Jan 20, 12:50
Altimmune EPS Diluted (Quarterly): -0.2126 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Viking Therapeutics, Inc. | -0.8083 |
| CorMedix, Inc. | 1.259 |
| Actinium Pharmaceuticals, Inc. | -0.1645 |
| Aldeyra Therapeutics, Inc. | -0.1279 |
| Seres Therapeutics, Inc. | 0.9353 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -19.01M |
| Revenue (Quarterly) | 0.005M |
| Total Expenses (Quarterly) | 19.02M |
| Enterprise Value | 247.50M |
| Gross Profit Margin (Quarterly) | -440.0% |
| Profit Margin (Quarterly) | -380.3K% |
| Earnings Yield | -25.45% |
| Normalized Earnings Yield | -25.45 |